Drug Type Recombinant protein |
Synonyms |
Target |
Mechanism NXNL1 stimulators(Nucleoredoxin like protein 1 stimulators) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Retinitis Pigmentosa | Discovery | FR | - |